Physician profile
Melissa Smith
NPI 1740521830
$1,999.94
in general payments reported to CMS, 2019-2025
10 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.66 · 2022: $159 · 2023: $605 · 2024: $1,080 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,152.71 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $230.99 | 2024-2025 | Evoque, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $130.91 | 2022-2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2024 | Wainua |
| Janssen Pharmaceuticals, INC | $117.71 | 2024 | Xarelto |
| Amgen INC. | $104.48 | 2024 | Repatha |
| Abbvie INC. | $50.06 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $44.40 | 2024 | Assure Wcd |
| Zoll Respicardia, INC. | $23.93 | 2025 | Remede System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.